Aminopyridine derived compounds as LRRK2 inhibitors
US9321748B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 30, 2013 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Dec 30, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to aminopyridine derived compounds of formula (A). The compounds are considered useful for the treatment of diseases associated with LRRK2 such a Lewy body dementia, Parkinson's disease or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.